Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-138021
Filing Date
2020-12-21
Accepted
2020-12-21 15:35:15
Documents
1
Period of Report
2020-12-17

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 7234
  Complete submission text file 0001104659-20-138021.txt   9860
Mailing Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2695
Atlas Venture Associates IX, LLC (Reporting) CIK: 0001671207 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4/A | Act: 34 | File No.: 001-38459 | Film No.: 201404185

Mailing Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2694
Atlas Venture Associates IX, L.P. (Reporting) CIK: 0001671208 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4/A | Act: 34 | File No.: 001-38459 | Film No.: 201404184

Mailing Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 46 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2694
Atlas Venture Fund IX, L.P. (Reporting) CIK: 0001671219 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4/A | Act: 34 | File No.: 001-38459 | Film No.: 201404183

Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)